167 related articles for article (PubMed ID: 28819773)
1. TLR9 gene polymorphism -1486T/C (rs187084) is associated with uterine cervical neoplasm in Mexican female population.
Martínez-Campos C; Bahena-Román M; Torres-Poveda K; Burguete-García AI; Madrid-Marina V
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2437-2445. PubMed ID: 28819773
[TBL] [Abstract][Full Text] [Related]
2. Gene Polymorphisms of Toll-Like Receptor 9 -1486T/C and 2848G/A in Cervical Cancer Risk.
Mu X; Zhao J; Yuan X; Zhao X; Yao K; Liu Y; Zhao X
Int J Gynecol Cancer; 2015 Sep; 25(7):1173-8. PubMed ID: 26270118
[TBL] [Abstract][Full Text] [Related]
3. Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
Pandey NO; Chauhan AV; Raithatha NS; Patel PK; Khandelwal R; Desai AN; Choxi Y; Kapadia RS; Jain ND
Sci Rep; 2019 Jul; 9(1):9729. PubMed ID: 31278284
[TBL] [Abstract][Full Text] [Related]
4. Association of toll-like receptor gene polymorphisms and its interaction with HPV infection in determining the susceptibility of cervical cancer in Chinese Han population.
Jin Y; Qiu S; Shao N; Zheng J
Mamm Genome; 2017 Jun; 28(5-6):213-219. PubMed ID: 28497211
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 9 (TLR9) gene polymorphisms associated with increased susceptibility of human papillomavirus-16 infection in patients with cervical cancer.
Lai ZZ; Ni-Zhang ; Pan XL; Song L
J Int Med Res; 2013 Aug; 41(4):1027-36. PubMed ID: 23816930
[TBL] [Abstract][Full Text] [Related]
6. Association of TLR4 and TLR9 gene polymorphisms with cervical HR-HPV infection status in Chinese Han population.
Zhang C; Yang Z; Luo P; Li T; Wang S; Sun F; Gong P; Mei B
BMC Infect Dis; 2023 Mar; 23(1):152. PubMed ID: 36915050
[TBL] [Abstract][Full Text] [Related]
7. TLR9 -1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants.
Paradowska E; Jabłońska A; Studzińska M; Skowrońska K; Suski P; Wiśniewska-Ligier M; Woźniakowska-Gęsicka T; Nowakowska D; Gaj Z; Wilczyński J; Leśnikowski ZJ
PLoS One; 2016; 11(4):e0154100. PubMed ID: 27105145
[TBL] [Abstract][Full Text] [Related]
8. A genetic variant in the promoter region of Toll-like receptor 9 and cervical cancer susceptibility.
Chen X; Wang S; Liu L; Chen Z; Qiang F; Kan Y; Shen Y; Wu J; Shen H; Hu Z
DNA Cell Biol; 2012 May; 31(5):766-71. PubMed ID: 22059466
[TBL] [Abstract][Full Text] [Related]
9. Association of IL-10 GTC haplotype with serum level and HPV infection in the development of cervical carcinoma.
Singhal P; Kumar A; Bharadwaj S; Hussain S; Bharadwaj M
Tumour Biol; 2015 Apr; 36(4):2287-98. PubMed ID: 25412954
[TBL] [Abstract][Full Text] [Related]
10. Association of
Zhang C; Yang Z; Luo P; Ye M; Gong P; Gong Q; Mei B
Biomark Med; 2023 Feb; 17(3):133-142. PubMed ID: 37097031
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms and haplotypes of TLR4, TLR9 and CYP1A1 genes possibly interfere with high-risk human papillomavirus infection and cervical cancer susceptibility in Jharkhand, India.
Nath N; Mishra P; Panda AK; Mishra R
Int Immunopharmacol; 2020 Nov; 88():106925. PubMed ID: 32871478
[TBL] [Abstract][Full Text] [Related]
12. Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development.
Roszak A; Lianeri M; Sowińska A; Jagodziński PP
Mol Biol Rep; 2012 Aug; 39(8):8425-30. PubMed ID: 22714906
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the TGFB1 signal peptide influence human papillomavirus infection and development of cervical lesions.
Trugilo KP; Cebinelli GCM; Berti FCB; Okuyama NCM; Cezar-Dos-Santos F; Sena MM; Mangieri LFL; Watanabe MAE; de Oliveira KB
Med Microbiol Immunol; 2019 Feb; 208(1):49-58. PubMed ID: 30167873
[TBL] [Abstract][Full Text] [Related]
14. Immunoexpression of HPV 16/18 E6 and E7 oncoproteins in high-grade cervical squamous intraepithelial lesions in HIV-positive women.
Rodrigues LC; Speck NM; Focchi GR; Schimidt MA; Marques RM; Ribalta JC
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909984
[TBL] [Abstract][Full Text] [Related]
15. TLR9 gene polymorphism (rs187084, rs352140): association with acute rejection and estimated glomerular filtration rate in renal transplant recipients.
Kim TH; Jeong KH; Kim SK; Lee SH; Ihm CG; Lee TW; Moon JY; Yoon YC; Chung JH; Park SJ; Kang SW; Kim YH
Int J Immunogenet; 2013 Dec; 40(6):502-8. PubMed ID: 23758740
[TBL] [Abstract][Full Text] [Related]
16. Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study.
Machalek DA; Wark JD; Tabrizi SN; Hopper JL; Bui M; Dite GS; Cornall AM; Pitts M; Gertig D; Erbas B; Garland SM
Twin Res Hum Genet; 2017 Feb; 20(1):10-18. PubMed ID: 27917752
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 2 gene polymorphisms in Korean women with human papillomavirus-related cervical neoplasia.
Kim JH; Key EY; Song MJ; Lee SJ; Kim CJ; Hur SY; Park TC; Kim TG; Park JS
Acta Obstet Gynecol Scand; 2016 Jul; 95(7):829-35. PubMed ID: 26988751
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Toll-Like Receptors 2/3/4/9 Gene Polymorphisms in Cervical Cancer Evolution.
Zidi S; Sghaier I; Gazouani E; Mezlini A; Yacoubi-Loueslati B
Pathol Oncol Res; 2016 Apr; 22(2):323-30. PubMed ID: 26548749
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in the DNA repair genes in HPV-positive cervical cancer.
Bajpai D; Banerjee A; Pathak S; Thakur B; Jain SK; Singh N
Eur J Cancer Prev; 2016 May; 25(3):224-31. PubMed ID: 25812040
[TBL] [Abstract][Full Text] [Related]
20. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
